Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds
{{output}}
BackgroundProstate-specific antigen (PSA) remains the most widely used biomarker for prostate cancer screening, diagnosis, and monitoring. However, despite decades of standardization efforts, significant inter-assay variability persists, with important consequ... ...
